rs4755798

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021926.4(ALX4):​c.*228C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.248 in 589,360 control chromosomes in the GnomAD database, including 19,205 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4422 hom., cov: 34)
Exomes 𝑓: 0.25 ( 14783 hom. )

Consequence

ALX4
NM_021926.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.09

Publications

7 publications found
Variant links:
Genes affected
ALX4 (HGNC:450): (ALX homeobox 4) This gene encodes a paired-like homeodomain transcription factor expressed in the mesenchyme of developing bones, limbs, hair, teeth, and mammary tissue. Mutations in this gene cause parietal foramina 2 (PFM2); an autosomal dominant disease characterized by deficient ossification of the parietal bones. Mutations in this gene also cause a form of frontonasal dysplasia with alopecia and hypogonadism; suggesting a role for this gene in craniofacial development, mesenchymal-epithelial communication, and hair follicle development. Deletion of a segment of chromosome 11 containing this gene, del(11)(p11p12), causes Potocki-Shaffer syndrome (PSS); a syndrome characterized by craniofacial anomalies, cognitive disability, multiple exostoses, and genital abnormalities in males. In mouse, this gene has been shown to use dual translation initiation sites located 16 codons apart. [provided by RefSeq, Oct 2009]
ALX4 Gene-Disease associations (from GenCC):
  • parietal foramina 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • frontonasal dysplasia with alopecia and genital anomaly
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet
  • parietal foramina
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 11-44264626-G-A is Benign according to our data. Variant chr11-44264626-G-A is described in ClinVar as Benign. ClinVar VariationId is 304694.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.267 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALX4NM_021926.4 linkc.*228C>T 3_prime_UTR_variant Exon 4 of 4 ENST00000652299.1 NP_068745.2 Q9H161

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALX4ENST00000652299.1 linkc.*228C>T 3_prime_UTR_variant Exon 4 of 4 NM_021926.4 ENSP00000498217.1 Q9H161

Frequencies

GnomAD3 genomes
AF:
0.235
AC:
35682
AN:
152128
Hom.:
4419
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.217
Gnomad ASJ
AF:
0.359
Gnomad EAS
AF:
0.127
Gnomad SAS
AF:
0.235
Gnomad FIN
AF:
0.213
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.270
Gnomad OTH
AF:
0.252
GnomAD4 exome
AF:
0.252
AC:
110200
AN:
437114
Hom.:
14783
Cov.:
4
AF XY:
0.251
AC XY:
57283
AN XY:
228086
show subpopulations
African (AFR)
AF:
0.190
AC:
2340
AN:
12320
American (AMR)
AF:
0.202
AC:
3527
AN:
17474
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
4932
AN:
13472
East Asian (EAS)
AF:
0.118
AC:
3583
AN:
30294
South Asian (SAS)
AF:
0.239
AC:
9921
AN:
41476
European-Finnish (FIN)
AF:
0.223
AC:
6516
AN:
29248
Middle Eastern (MID)
AF:
0.283
AC:
540
AN:
1910
European-Non Finnish (NFE)
AF:
0.272
AC:
72357
AN:
265572
Other (OTH)
AF:
0.256
AC:
6484
AN:
25348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
3983
7967
11950
15934
19917
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
430
860
1290
1720
2150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.234
AC:
35698
AN:
152246
Hom.:
4422
Cov.:
34
AF XY:
0.231
AC XY:
17198
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.190
AC:
7902
AN:
41564
American (AMR)
AF:
0.217
AC:
3318
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.359
AC:
1246
AN:
3472
East Asian (EAS)
AF:
0.127
AC:
654
AN:
5166
South Asian (SAS)
AF:
0.234
AC:
1127
AN:
4824
European-Finnish (FIN)
AF:
0.213
AC:
2266
AN:
10620
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.270
AC:
18351
AN:
67974
Other (OTH)
AF:
0.250
AC:
529
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1453
2906
4359
5812
7265
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.248
Hom.:
634
Bravo
AF:
0.233
Asia WGS
AF:
0.190
AC:
660
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Parietal foramina 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.41
DANN
Benign
0.84
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4755798; hg19: chr11-44286176; API